Trial Profile
A phase 1 trial of ALXN5500.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 23 Mar 2022
Price :
$35
*
At a glance
- Drugs ALXN 5500 (Primary)
- Indications Immunological disorders
- Focus Adverse reactions
- Sponsors Alexion AstraZeneca Rare Disease
- 02 Feb 2015 New trial record